Celldex Therapeutics reported $-63857000 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Amgen USD 2.26B 1.34B Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Celldex Therapeutics USD -63857000 1.12M Jun/2025
Glaxosmithkline GBP 2.07B 237.99M Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024